All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Recent trends in transdermal cardiovascular therapy

Author(s): VG Jamakandi1, B Ghosh1, BG Desai1, J Khanam2
1Department of Pharmaceutics, K. L. E. S's College of Pharmacy, II Block, Rajajinagar, Bangalore-560 010, India 2Department of Pharmaceutical Technology, Jadavpur University, Kolkata-700 032, India

Correspondence Address:
B Ghosh Department of Pharmaceutics, K. L. E. S's College of Pharmacy, II Block, Rajajinagar, Bangalore-560 010 India E-mail: [email protected]


Transdermal dosage forms, though a costly alternative to the conventional formulations, are becoming popular because of some unique advantages. Controlled zero-order absorption, simple administration mode and the option of easy removal in case of adverse manifestations make them particularly desirable in cardiovascular therapy. Nitroglycerin and isosorbide dinitrate, the two antiischaemic drugs; and clonidine, an antihypertensive molecule, are being extensively used in the transdermal form. Studies that compared these patches with the established dosage forms had shown that though patches were costlier than conventional prescription products, they reduced the occurrence of hospitalization and diagnostic costs. Currently a number of antihypertensive drugs are being developed for transdermal administration. This article reviews the research on cardiovascular patches as well as the marketed products.



Share this